Researchers at the University of Michigan have developed a new method that brings quantum-level accuracy to molecular modeling, offering fresh insights into a widely used simulation approach in ...
Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results